Protective effect of immunosuppression on granulation tissue formation in metallic airway stents

Laryngoscope

Volumn 118, Issue 8, 2008, Pages 1383-1388

  Shlomi, Dekel ^a,b   Peled, Nir ^a   Shitrit, David ^a   Bendayan, Daniele ^a   Amital, Anat ^a   Kramer, Mordechai R ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b NONE

Author keywords

Brachytherapy; Bronchoscopy; Laser; Tacrolimus

Indexed keywords

AZATHIOPRINE; COTRIMOXAZOLE; CYCLOSPORIN; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; VALGANCICLOVIR;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; ASPERGILLOSIS; BARE METAL STENT; BRACHYTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY STENT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG SUBSTITUTION; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRANULATION TISSUE; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LASER SURGERY; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MALE; PNEUMOCYSTIS CARINII; PNEUMOCYSTOSIS; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT DURATION; TREATMENT OUTCOME; BRONCHOSCOPY; DRUG EFFECT; DYSPNEA; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; STENT; TRACHEA STENOSIS; WOUND DEHISCENCE;

ADULT; AGED; AIRWAY OBSTRUCTION; BRONCHOSCOPY; DYSPNEA; FEMALE; GRANULATION TISSUE; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; LUNG TRANSPLANTATION; MALE; METHYLPREDNISOLONE; MIDDLE AGED; STENTS; SURGICAL WOUND DEHISCENCE; TACROLIMUS; TRACHEAL STENOSIS;

EID: 49649085877     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLG.0b013e318172d686     Document Type: Article

References (26)

1. Wood DE. Airway stenting. Chest Surg Clin North Am 2001;11:841-860.
2. Kshettry VR, Kroshus TJ, Hertz MI, Hunter DW, Sumway SJ, Bolman RM III. Early and late airway complications after lung transplantation: incidence and management. Ann Thorac Surg 1997;63:1576-1583.
3. de Hoyos AL, Patterson GA, Maurer JR, Ramirez JC, Miller JD, Winton TL. Pulmonary transplantation. Early and late results. The Toronto Lung Transplant Group. J Thorac Cardiovasc Surg 1992;103:295-306.
4. Wilson IC, Hasan A, Healey M, et al. Healing of the bronchus in pulmonary transplantation. Eur J Cardiothorac Surg 1996;10:521-527.
5. Schmid RA, Boehler A, Speich R, Frey JR, Russi EW, Weder W. Bronchial anastomotic complications following lung transplantation: still a major cause of morbidity? Eur Respir J 1997;10:2872-2875.
6. Alvarez A, Algar J, Santos F, et al. Airway complications after lung transplantation: a review of 151 anastomoses. Eur J Cardiothorac Surg 2001;19:381-387.
7. Mughal MM, Gildea TR, Murthy S, Pettersson G, DeCamp M, Mehta AC. Short-term deployment of self-expanding metallicstents facilitates healing of bronchial dehiscence. Am J Respir Crit Care Med 2005;172:768-771.
8. Burningham AR, Wax MK, Andersen PE, Everts EC, Cohen JI. Metallic tracheal stents: complications associated with long-term use in the upper airway. Ann Otol Rhinol Laryngol 2002;111:285-290.
9. Chhajed PN, Malouf MA, Tamm M, Spratt P, Glanville AR. Interventional bronchoscopy for the management of airway complications following lung transplantation. Chest 2001;120:1894-1899.
10. Moses JW, Leon MB, Popma JJ, et al. SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323.
11. Fajadet J, Morice MC, Bode C, et al. Maintenance of longterm clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial. Circulation 2005;111:1040-1044.
12. Kramer MR, Katz A, Yarmolovsky A, Schifter D, Fenig E. Successful use of high dose rate brachytherapy for nonmalignant bronchial obstruction. Thorax 2001;56: 415-416.
13. Kennedy AS, Sonett JR, Orens JB, King K. High dose rate brachytherapy to prevent recurrent benign hyperplasia in lung transplant bronchi: theoretical and clinical considerations. J Heart Lung Transplant 2000;19:155-159.
14. Halkos ME, Godette KD, Lawrence EC, Miller JI Jr. High dose rate brachytherapy in the management of lung transplant airway stenosis. Ann Thorac Surg 2003;76:381-384.
15. Chu WW, Torguson R, Pichard AD, et al. Drug-eluting stents versus repeat vascular brachytherapy for patients with recurrent in-stent restenosis after failed intracoronary radiation. J Invasive Cardiol 2005;17:659-662.
16. Saad CP, Murthy S, Krizmanich G, Mehta AC. Self-expandable metallic airway stents and flexible bronchoscopy: long-term outcomes analysis. Chest 2003;124:1993-1999.
17. Arruda JA, Costa MA, Brito FS Jr, et al. Effect of systemic immuno-suppression on coronary in-stent intimal hyperplasia in renal transplant patients. Am J Cardiol 2003;91:1363-1365.
18. Brito FS Jr, Rosa WC, Arruda JA, Tedesco H, Pestana JO, Lima VC. Efficacy and safety of oral sirolimus to inhibit in-stent intimal hyperplasia. Catheter Cardiovasc Interv 2005;64:413-418.
19. Hausleiter J, Kastrati A, Mehilli J, et al. OSIRIS Investigators. Randomized, double-blind, placebo- controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial. Circulation 2004;110:790-795.
20. Rodriguez AE, Rodriguez Alemparte M, Vigo CF, et al. Role of oral rapamycin to prevent restenosis in patients with de novo lesions undergoing coronary stenting: results of the Argentina single centre study (ORAR trial). Heart 2005;91: 1433-1437.
21. Deuse T, Schrepfer S, Koch-Nolte F, et al. FK778 and tacrolimus prevent the development of obliterative airway disease after heterotopic rat tracheal transplantation. J Heart Lung Transplant 2005;24:1844-1854.
22. Mohacsi PJ, Tuller D, Hulliger B, Wijngaard PL. Different inhibitory effects of immunosuppressive drugs on human and rat aortic smooth muscle and endothelial cell proliferation stimulated by platelet-derived growth factor or endothelial cell growth factor. J Heart Lung Transplant 1997;16:484-492.
23. Guilbeau JM. Delayed wound healing with sirolimus after liver transplant. Ann Pharmacother 2002;36:1391-1395.
24. Groetzner J, Kur F, Spelsberg F, et al. Munich Lung Transplant Group. Airway anastomosis complications in de novo lung transplantation with sirolimus-based immunosuppression. J Heart Lung Transplant 2004;23:632-638.
25. Choong CK, Haddad FJ, Gee EY, Cooper JD. Feasibility and safety of airway bypass stent placement and influence of topical mitomycin C on stent patency. J Thorac Cardiovasc Surg 2005;129:632-638.
26. Choong CK, Phan L, Massetti P, et al. Prolongation of patency of airway bypass stents with use of drug-eluting stents. J Thorac Cardiovasc Surg 2006;131:60-64.